Honore Tage sold Vanda Pharmaceuticals Inc. ($VNDA) shares once on the open market in the last 365 days for a total of $240,900. The most recent VNDA insider sale occurred on February 23, 2026. This ranks 8,042nd among 11,678 insiders by sale value, well below the average of $8.6 million across 6.4 transactions. Honore Tage made no open market purchases of VNDA stock.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2026 | Vanda Pharmaceuticals Inc. | $VNDA | Honore Tage | Not found | S | Common Stock | 30000 | $8.03 | 93,469.0000 | 59,108,030 | 24.30% | 0.05% |
| June 5, 2025 | Vanda Pharmaceuticals Inc. | $VNDA | Honore Tage | Not found | A | Common Stock | 59225 | $0.00 | 123,469.0000 | 58,316,044 | 92.19% | 0.10% |
| May 17, 2024 | Vanda Pharmaceuticals Inc. | $VNDA | Honore Tage | Not found | A | Common Stock | 20529 | $0.00 | 64,244.0000 | 0 | 46.96% | 0.00% |
| May 17, 2024 | Vanda Pharmaceuticals Inc. | $VNDA | Honore Tage | Not found | A | Stock Option (right to buy) | 37578 | $0.00 | 37,578.0000 | 0 | 9999.99% | 0.00% |